NasdaqCM - Delayed Quote USD

KORU Medical Systems, Inc. (KRMD)

2.6600
-0.0600
(-2.21%)
At close: May 23 at 4:00:01 PM EDT
2.6600
0.00
(0.00%)
After hours: May 23 at 4:04:06 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Linda M. Tharby President, CEO & Director 718.33k -- 1968
Mr. Thomas Adams CFO, Secretary & Treasurer 413.85k -- 1973
Mr. Christopher Pazdan Chief Operating Officer -- -- 1983
Mr. Rob Cannon Interim Chief Commercial Officer -- -- --

KORU Medical Systems, Inc.

100 Corporate Drive
Mahwah, NJ 07430
United States
845-469-2042 https://www.korumedical.com
Sector: 
Healthcare
Full Time Employees: 
80

Description

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 and FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

Corporate Governance

KORU Medical Systems, Inc.’s ISS Governance QualityScore as of May 1, 2025 is 1. The pillar scores are Audit: 7; Board: 3; Shareholder Rights: 1; Compensation: 5.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 7, 2025 at 8:05 PM UTC

KORU Medical Systems, Inc. Earnings Date

Recent Events

May 15, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 7, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 7, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 4, 2025 at 12:00 AM UTC

DEF 14A: Proxy Statements

March 12, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 13, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 13, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 21, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 7, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 24, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers